The purpose of this study was to investigate the efficacy of decision support intervention on treatment knowledge, decision self-efficacy, decisional conflict, and decision satisfaction in patients with hepatocellular cancer. The study was a randomized controlled trial. In all, 69 patients with hepatocellular carcinoma (HCC) were recruited and randomly assigned to a decision support group or a control group. Data were collected at baseline, post-test, and follow-up using self-report questionnaires. After controlling for baseline scores, the between-group difference (95% confidence interval [CI]) for treatment-related knowledge in post-test scores was 11.9 (6.1, 17.8). After controlling for baseline scores, the between-group difference (95% CI) for decisional conflict was −7.0 (−12.0, −2.0). There was no statistically significant between-group difference in decision self-efficacy and decision satisfaction. Findings supported the efficacy of decision support intervention to improve treatment knowledge and reduce decisional conflict but had no significant effect on decision self-efficacy and decision satisfaction in patients with HCC.
Baca-DietzD.WojnarD. M.EspinaC. R. (2020). The shared decision-making model: Providers’ and patients’ knowledge and understanding in clinical practice. Journal of the American Association of Nurse Practitioners, 33(7), 529–536. https://doi.org/10.1097/JXX.0000000000000401
2.
BanduraA. (1997). Self-efficacy: The exercise of control. Freeman.
3.
BunnH.O’ConnorA. (1996). Validation of client decision-making instruments in the context of psychiatry. Canadian Journal of Nursing Research, 28(3), 13–27.
4.
ChongW. Q.MogroM. J.ArsadA.TaiB. C.LeeS. C. (2021). Use of decision aid to improve informed decision-making and communication with physicians on the use of oral complementary and alternative medicine (CAM) among cancer patients on chemotherapy treatment: A randomised controlled trial. Supportive Care in Cancer, 29(7), 3689–3696. https://doi.org/10.1007/s00520-020-05872-5
5.
CoxC. L.MillerB. M.KuhnI.FritzZ. (2021). Diagnostic uncertainty in primary care: What is known about its communication and the associated ethical issues?Family Practice, 38(5), 654–668. https://doi.org/10.1093/fampra/cmab023
6.
ElwynG.FroschD.ThomsonR.Joseph-WilliamsN.LloydA.KinnersleyP.CordingE.TomsonD.DoddC.RollnickS.EdwardsA.BarryM. (2012). Shared decision making: a model for clinical practice. Journal of General Internal Medicine, 27(10), 1361–1367. https://doi.org/10.1007/s11606-012-2077-6
7.
ErstadD. J.TanabeK. K. (2017). Hepatocellular carcinoma: Early-stage management challenges. Journal of Hepatocellular Carcinoma, 4, 81–92. https://doi.org/10.2147/jhc.S10737
8.
FaimanB.TarimanJ. D. (2019). Shared decision making: Improving patient outcomes by understanding the benefits of and barriers to effective communication. Clinical Journal of Oncology Nursing, 23(5), 540–542. https://doi.org/10.1188/19.CJON.540-542
9.
FaulF.ErdfelderE.BuchnerA.LangA. G. (2009). Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods, 41(4), 1149–1160. https://doi.org/10.3758/BRM.41.4.1149
10.
GaoJ. P.JinY. H.YuS. F.WuW. F.HanS. F. (2021). Evaluate the effectiveness of breast cancer decision aids: A systematic review and meta-analysis of randomized clinical trials. Nursing Open, 8(5), 2091–2104. https://doi.org/10.1002/nop2.741
11.
HeimbachJ. K.KulikL. M.FinnR. S.SirlinC. B.AbecassisM. M.RobertsL. R.MarreroJ. A. (2018). AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology, 67(1), 358–380. https://doi.org/10.1002/hep.29086
12.
Holmes-RovnerM.KrollJ.SchmittN.RovnerD. R.BreerM. L.RothertM. L.TalarczykG. (1996). Patient satisfaction with health care decisions: The satisfaction with decision scale. Medical Decision Making, 16(1), 58–64. https://doi.org/10.1177/0272989X9601600114
13.
JohnsonR.TurnerK.FederG.CramerH. (2021). Shared decision making in consultations for hypertension: Qualitative study in general practice. Health Expectations, 24(3), 917–929. https://doi.org/10.1111/hex.13234
LamW. W.KwokM.LiaoQ.ChanM.OrA.KwongA.SuenD.FieldingR. (2015). Psychometric assessment of the Chinese version of the decisional conflict scale in Chinese women making decision for breast cancer surgery. Health Expect, 18(2), 210–220. https://doi.org/10.1111/hex.12021
16.
LeeM. K.Bryant-LukosiusD. (2021). Information provision, decision self-efficacy, and decisional conflict in adopting health behaviors among patients treated for colorectal cancer: A cross-sectional study. Cancer Nursing. Advance online publication. https://doi.org/10.1097/NCC.0000000000001040
17.
MarreroJ. A.KulikL. M.SirlinC. B.ZhuA. X.FinnR. S.AbecassisM. M.HeimbachJ. K. (2018). Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology, 68(2), 723–750. https://doi.org/10.1002/hep.29913
18.
MartiniG.CiardielloD.ParagliolaF.NaccaV.SantanielloW.UrraroF.StanzioneM.NiosiM.DallioM.FedericoA.SelvaggiF.Della CorteC. M.NapolitanoS.CiardielloF.MartinelliE. (2021). How immunotherapy has changed the continuum of care in hepatocellular carcinoma. Cancers, 13(18), 4719. https://doi.org/10.3390/cancers13184719
MetzM. JVeerbeekM. A.ElfeddaliI.de BeursEvan der Feltz-CornelisC. M.BeekmanA. T. F. (2018). Providing insight into the construct decisional conflict and its usability to assess shared decision making. Tijdschrift voor Psychiatrie, 60(6), 397–402.
21.
MohammedE. S.SeedhomA. E.GhazawyE.R. (2017). Awareness and practice of patient rights from a patient perspective: an insight from Upper Egypt. International Journal for Quality in Health Care, 30(2), 145–151. https://doi.org/10.1093/intqhc/mzx182
PáezG.ForteD. N.GabeirasM. (2021). Exploring the relationship between shared decision-making, patient-centered medicine, and evidence-based medicine. The Linacre Quarterly, 88(3), 272–280. https://doi.org/10.1177/00243639211018355
26.
ReigM.FornerA.RimolaJ.Ferrer-FàbregaJ.BurrelM.Garcia-CriadoÁ.KelleyR. K.GalleP. R.MazzaferroV.SalemR.SangroB.SingalA. G.VogelA.FusterJ.AyusoC.BruixJ. (2022). BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. Journal of Hepatology, 76(3), 681–693. https://doi.org/10.1016/j.jhep.2021.11.018
27.
RoeA. K.EpplerS. L.ShapiroL. M.SattesonE. S.YaoJ.KamalR. N. (2021). Engaging patients to ask more questions: What’s the best way? A pragmatic randomized controlled trial. The Journal of Hand Surgery, 46(9), 818.e1–818.e6. https://doi.org/10.1016/j.jhsa.2021.02.001
28.
SaghaeiM. (2004). Random allocation software for parallel group randomized trials. BMC Medical Research Methodology, 4, 26. https://doi.org/10.1186/1471-2288-4-26
29.
SchapiraM. M.ChhatreS.PriggeJ. M.MelineJ.KaminsteinD.RodriguezK. L.FraenkelL.KravetzJ. D.WhittleJ.BastianL. A.VachaniA.AkersS.SchrandS.IbarraJ. V.AsanO. (2022). A veteran-centric web-based decision aid for lung cancer screening: usability analysis. JMIR Formative Research, 6(4), e29039. https://doi.org/10.2196/29039
30.
SchulzK.F.AltmanD.G.MoherD.& The CONSORT Group (2010). CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology, 63(8), 834–840. https://doi.org/10.1016/j.jclinepi.2010.02.005
31.
ShaoY. Y.WangS. Y.LinS. M., Diagnosis Group, & Systemic Therapy Group (2021). Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. Journal of the Formosan Medical Association = Taiwan yi zhi, 120(4), 1051–1060. https://doi.org/10.1016/j.jfma.2020.10.031
32.
ShunS. C.ChouY. J.ChenC. H.YangJ. C. (2018). Change of uncertainty in illness and unmet care needs in patients with recurrent hepatocellular carcinoma during active treatment. Cancer Nursing, 41(4), 279–289. https://doi.org/10.1097/NCC.0000000000000487.
33.
SmithC. A.ChangE.GallegoG.KhanA.ArmourM.BalneavesL. G. (2019). An education intervention to improve decision making and health literacy among older Australians: A randomised controlled trial. BMC Geriatrics, 19(1), 129. https://doi.org/10.1186/s12877-019-1143-x
34.
StaceyD.LégaréF.BolandL.LewisK. B.LoiselleM. C.HoefelL.GarvelinkM.O’ConnorA. (2020). 20th anniversary Ottawa Decision Support Framework: Part 3 overview of systematic reviews and updated framework. Medical Decision Making, 40(3), 379–398. https://doi.org/10.1177/0272989X20911870
35.
StaceyD.LégaréF.LewisK.BarryM. J.BennettC. L.EdenK. B.Holmes-RovnerM.Llewellyn-ThomasH.LyddiattA.ThomsonR.TrevenaL. (2017a). Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews, 4, CD001431. https://doi.org/10.1002/14651858.CD001431.pub5
36.
StaceyD.O’ConnorA.BreauR. (2017b). Patient decision aids. Ottawa Hospital Research Institute. https://decisionaid.ohri.ca/
37.
SteenbeekM. P.van BommelM.HarmsenM. G.HoogerbruggeN.van DoornH. C.KeurentjesJ.van BeurdenM.ZweemerR. P.GaarenstroomK. N.PendersC.Brood-van ZantenM.VosM. C.PiekJ. M.van LonkhuijzenL.ApperlooM.CoppusS.IntHoutJ.de HulluJ. A.HermensR. (2021). Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy. Gynecologic Oncology, 163(2), 371–377. https://doi.org/10.1016/j.ygyno.2021.08.019
38.
SungH.FerlayJ.SiegelR. L.LaversanneM.SoerjomataramI.JemalA.BrayF. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
39.
Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Local Ablation Group, TACE/TARE/HAI Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group (2018). Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. Journal of the Formosan Medical Association = Taiwan yi zhi, 117(5), 381–403. https://doi.org/10.1016/j.jfma.2017.09.007
40.
WangS.LuQ.YeZ.LiuF.YangN.PanZ.LiY.LiL. (2022). Effects of a smartphone application named “Shared Decision Making Assistant” for informed patients with primary liver cancer in decision-making in China: A quasi-experimental study. BMC Medical Informatics and Decision Making, 22(1), 145. https://doi.org/10.1186/s12911-022-01883-w
41.
WangT.-J.ChiuP.-P.ChenK.-K.HungL.-P. (2021). Efficacy of a decision support intervention for reducing decisional conflict in patients with elevated serum prostate-specific antigen: A randomized controlled trial. European Journal of Oncology Nursing, 50, 101865. https://doi.org/10.1016/j.ejon.2020.101865
42.
WillsC. E.Holmes-RovnerM. (2003). Preliminary validation of the Satisfaction With Decision scale with depressed primary care patients. Health Expectations, 6(2), 149–159. https://doi.org/10.1046/j.1369-6513.2003.00220.x
43.
YamauchiK.NakaoM.NakashimaM. (2019). Correlates of regret with treatment decision-making among Japanese women with breast cancer: Results of an internet-based cross-sectional survey. BMC Women’s Health, 19(1), 86. https://doi.org/10.1186/s12905-019-0783-5
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
